Pseudomonas aeruginosa

"Pseudomonas aeruginosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.

Descriptor ID	D011550
MeSH Number(s)	B03.440.400.425.625.625.100 B03.660.250.580.590.050
Concept/Terms	Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas pyocyanea

Below are MeSH descriptors whose meaning is more general than "Pseudomonas aeruginosa".

Organisms [B]
Bacteria [B03]
Gram-Negative Bacteria [B03.440]
Gram-Negative Aerobic Bacteria [B03.440.400]
Gram-Negative Aerobic Rods and Cocci [B03.440.400.425]
Pseudomonadaceae [B03.440.400.425.625]
Pseudomonas [B03.440.400.425.625.625]
Pseudomonas aeruginosa [B03.440.400.425.625.625.100]
Proteobacteria [B03.660]
Gammaproteobacteria [B03.660.250]
Pseudomonadaceae [B03.660.250.580]
Pseudomonas [B03.660.250.580.590]
Pseudomonas aeruginosa [B03.660.250.580.590.050]

Below are MeSH descriptors whose meaning is related to "Pseudomonas aeruginosa".

Below are MeSH descriptors whose meaning is more specific than "Pseudomonas aeruginosa".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pseudomonas aeruginosa" by people in this website by year, and whether "Pseudomonas aeruginosa" was a major or minor topic of these publications.

Bar chart showing 85 publications over 24 distinct years, with a maximum of 7 publications in 2009 and 2012 and 2016 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	1	2
1998	1	0	1
2004	3	1	4
2005	1	0	1
2006	1	1	2
2007	3	0	3
2008	0	2	2
2009	4	3	7
2010	5	0	5
2011	2	1	3
2012	4	3	7
2013	2	0	2
2014	3	3	6
2015	0	3	3
2016	4	3	7
2017	2	1	3
2018	0	2	2
2019	3	4	7
2020	2	2	4
2021	3	1	4
2023	0	3	3
2024	3	1	4
2025	1	1	2

Below are the most recent publications written about "Pseudomonas aeruginosa" by people in Profiles.

Truong-Bolduc QC, Wang Y, Lawton BG, Zweifach JJ, McDevitt GM, El Abdellaoui Y, Brown Harding H, Yonker LM, Rahme LG, Vyas JM, Hooper DC. NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2025 08 06; 69(8):e0046025.

View in: PubMed
Yu X, Song Y, Dong T, Ouyang W, Quan C, Shao L, Barasa L, Thompson PR, Zhang M, Ma J, Kurabayashi K, Li Y. Citrullination of NF-?B p65 by PAD2 as a Novel Therapeutic Target for Modulating Macrophage Polarization in Acute Lung Injury. Adv Sci (Weinh). 2025 May; 12(18):e2413253.

View in: PubMed
Raviranga NGH, Ayinla M, Perera HA, Qi Y, Yan M, Ramstr?m O. Antimicrobial Potency of Nor-Pyochelin Analogues and Their Cation Complexes against Multidrug-Resistant Pathogens. ACS Infect Dis. 2024 Nov 08; 10(11):3842-3852.

View in: PubMed
Tse-Kang SY, Wani KA, Peterson ND, Page A, Humphries F, Pukkila-Worley R. Intestinal immunity in C.?elegans is activated by pathogen effector-triggered aggregation of the guard protein TIR-1 on lysosome-related organelles. Immunity. 2024 10 08; 57(10):2280-2295.e6.

View in: PubMed
Dong T, Barasa L, Yu X, Ouyang W, Shao L, Quan C, Wang SH, Zhang J, Salmon M, Tsung A, Alam HB, Ma J, Thompson PR, Li Y. AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment-Efficacy and Mechanism. Int J Biol Sci. 2024; 20(13):5043-5055.

View in: PubMed
Truong-Bolduc QC, Wang Y, Lawton BG, Brown Harding H, Yonker LM, Vyas JM, Hooper DC. Phenazine-1 carboxylic acid of Pseudomonas aeruginosa induces the expression of Staphylococcus aureus Tet38 MDR efflux pump and mediates resistance to phenazines and antibiotics. Antimicrob Agents Chemother. 2024 08 07; 68(8):e0063624.

View in: PubMed
Gras E, Vu TTT, Nguyen NTQ, Tran VG, Mao Y, Tran ND, Mai NH, Dong OX, Jung DH, Iorio NLPP, Povoa HCC, Pinheiro MG, Aguiar-Alves F, Weiss WJ, Zheng B, Cheng LI, Stover CK, Sellman BR, DiGiandomenico A, Gibault L, Valour F, Diep BA. Development and validation of a rabbit model of Pseudomonas aeruginosa non-ventilated pneumonia for preclinical drug development. Front Cell Infect Microbiol. 2023; 13:1297281.

View in: PubMed
Mirza Z, Walhout AJM, Ambros V. A bacterial pathogen induces developmental slowing by high reactive oxygen species and mitochondrial dysfunction in Caenorhabditis elegans. Cell Rep. 2023 10 31; 42(10):113189.

View in: PubMed
Peterson ND, Tse SY, Huang QJ, Wani KA, Schiffer CA, Pukkila-Worley R. Non-canonical pattern recognition of a pathogen-derived metabolite by a nuclear hormone receptor identifies virulent bacteria in C.?elegans. Immunity. 2023 04 11; 56(4):768-782.e9.

View in: PubMed
Wu T, Gagnon A, McGourty K, DosSantos R, Chanetsa L, Zhang B, Bello D, Kelleher SL. Zinc Exposure Promotes Commensal-to-Pathogen Transition in Pseudomonas aeruginosa Leading to Mucosal Inflammation and Illness in Mice. Int J Mol Sci. 2021 Dec 11; 22(24).

View in: PubMed

People

Explore

Similar Concepts

Top Journals